DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FIBRIN
1
Unknown
Investigational
Unknown
Unknown
Aging; Burns; Hernia, Ventral; Diabetic Foot; Hematoma; Periodontitis; Rotator Cuff Injuries; Tennis Elbow; Anus Diseases; Breast Neoplasms; Digestive System Diseases; Endometrial Neoplasms; Erectile Dysfunction; Hemorrhage; Joint Diseases; Lymphedema; Periodontal Diseases; Peripheral Vascular Diseases; Postoperative Complications; Pterygium; Thyroid Neoplasms; Tympanic Membrane Perforation; Uterine Cervical Neoplasms; Wounds and Injuries
Unknown
FIBRIN
×
Maximum Phase:
1
First Approval:
None
UNII:
AQ4K8I4R6F
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BMS-986179
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986179
×
Maximum Phase:
1
First Approval:
None
UNII:
7PO9B4VQ1U
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK3207
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
MK3207
×
Maximum Phase:
1
First Approval:
None
UNII:
5C44M1QYCC
Molecule Type:
Small molecule
Molecular Formula:
C31H29F2N5O3
Molecular Weight:
557.6
AlogP:
3.77
PSA:
103.43
HBD:
3.0
HBA:
#RotB:
4.0
Source:
VESIGENURTUCEL-L
1
Cell
Investigational
Unknown
Unknown
Urinary Bladder Neoplasms
Unknown
VESIGENURTUCEL-L
×
Maximum Phase:
1
First Approval:
None
UNII:
9IE620X9FY
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALFADEX
1
Oligosaccharide
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
ALFADEX
×
Maximum Phase:
1
First Approval:
None
UNII:
Z1LH97KTRM
Molecule Type:
Oligosaccharide
Molecular Formula:
C36H60O30
Molecular Weight:
972.85
AlogP:
-13.05
PSA:
474.9
HBD:
18.0
HBA:
#RotB:
6.0
Source:
METHYL P-TOLUENESULFONYL-L-ARGININATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYL P-TOLUENESULFONYL-L-ARGININATE
×
Maximum Phase:
1
First Approval:
None
UNII:
1H7BKF44U1
Molecule Type:
Small molecule
Molecular Formula:
C14H22N4O4S
Molecular Weight:
342.42
AlogP:
-0.13
PSA:
136.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TAS0612
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
p90RSK inhibitor
TAS0612
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H36F3N9O
Molecular Weight:
571.65
AlogP:
4.4
PSA:
119.79
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOHEXANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYCLOHEXANE
×
Maximum Phase:
1
First Approval:
None
UNII:
48K5MKG32S
Molecule Type:
Small molecule
Molecular Formula:
C6H12
Molecular Weight:
84.16
AlogP:
2.34
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
AMG-224
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AMG-224
×
Maximum Phase:
1
First Approval:
None
UNII:
Y69B45U0TK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IMGN-632
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
IMGN-632
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABT-107
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-107
×
Maximum Phase:
1
First Approval:
None
UNII:
SXS38HR98H
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O
Molecular Weight:
320.4
AlogP:
3.1
PSA:
54.04
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NARATUXIMAB EMTANSINE
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
NARATUXIMAB EMTANSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
WE1X5A83B9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOC31-PE
1
Antibody
Investigational
Unknown
Unknown
Carcinoma
Epithelial cell adhesion molecule binding agent
MOC31-PE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986166
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
BMS-986166
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.39
PSA:
55.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
CAGRILINTIDE
1
Protein
Investigational
Unknown
Unknown
Obesity
Unknown
CAGRILINTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
71
72
73
74
75
76
77
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA